Affordable Access

Publisher Website

Gender differences in prolactin elevation induced by olanzapine in Japanese drug-naïve schizophrenic patients

Authors
Journal
Progress in Neuro-Psychopharmacology and Biological Psychiatry
0278-5846
Publisher
Elsevier
Publication Date
Volume
30
Issue
8
Identifiers
DOI: 10.1016/j.pnpbp.2006.05.011
Keywords
  • Antipsychotics
  • Gender Difference
  • Olanzapine
  • Plasma Prolactin Level
  • Schizophrenia
  • Side Effects
Disciplines
  • Medicine

Abstract

Abstract We investigated the effect of gender on plasma prolactin levels in 20 Japanese drug-naïve schizophrenic patients [10 male, 10 female, aged 25.4 ± 10.3 (mean ± S.D.), range = 12–46 years] treated with olanzapine. Plasma prolactin levels were measured at baseline, and weeks 3 and 8 after starting titration of olanzapine. Comparisons of plasma prolactin levels between baseline and week 3, and between baseline and week 8 were made by repeated analysis of variance (ANOVA) and paired t-test. Two-way ANOVA showed a significant difference in olanzapine-induced prolactin changes between male and female patients ( P = 0.037). In male patients ( n = 10), the plasma concentration of prolactin at week 3 was significantly higher than at baseline ( P = 0.016), but there was no significant difference between the plasma concentration of prolactin at week 8 and at baseline or week 3 ( P = 0.191). In female patients ( n = 10), there was a significant change of prolactin between baseline and week 3 ( P = 0.005), and between baseline and week 8 ( P = 0.047). Our results indicate the possibility of gender differences in prolactin elevation induced by olanzapine in Japanese drug-naïve schizophrenic patients. These gender-based findings may be helpful for clinicians when deciding the frequency of follow-up visits once a patient starts olanzapine therapy.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments